These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21617646)

  • 1. Uropathogenic bacteria leave a mark.
    Schulz WA
    Lab Invest; 2011 Jun; 91(6):816-8. PubMed ID: 21617646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells.
    Tolg C; Sabha N; Cortese R; Panchal T; Ahsan A; Soliman A; Aitken KJ; Petronis A; Bägli DJ
    Lab Invest; 2011 Jun; 91(6):825-36. PubMed ID: 21242958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs).
    Behzadi P
    Folia Microbiol (Praha); 2020 Feb; 65(1):45-65. PubMed ID: 31165977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Regulation of the Diguanylate Cyclase YaiC Reduces Production of Type 1 Fimbriae in a Pst Mutant of Uropathogenic Escherichia coli CFT073.
    Crépin S; Porcheron G; Houle S; Harel J; Dozois CM
    J Bacteriol; 2017 Dec; 199(24):. PubMed ID: 28924030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. sRNA-Mediated Regulation of P-Fimbriae Phase Variation in Uropathogenic Escherichia coli.
    Khandige S; Kronborg T; Uhlin BE; Møller-Jensen J
    PLoS Pathog; 2015 Aug; 11(8):e1005109. PubMed ID: 26291711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
    Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
    mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bessaiah H; Pokharel P; Habouria H; Houle S; Dozois CM
    Front Cell Infect Microbiol; 2019; 9():312. PubMed ID: 31555608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UbiI (VisC) Aerobic Ubiquinone Synthase Is Required for Expression of Type 1 Pili, Biofilm Formation, and Pathogenesis in Uropathogenic Escherichia coli.
    Floyd KA; Mitchell CA; Eberly AR; Colling SJ; Zhang EW; DePas W; Chapman MR; Conover M; Rogers BR; Hultgren SJ; Hadjifrangiskou M
    J Bacteriol; 2016 Oct; 198(19):2662-72. PubMed ID: 27161114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uropathogenic Escherichia coli infection: potential importance of epigenetics.
    Tolg C; Bägli DJ
    Epigenomics; 2012 Apr; 4(2):229-35. PubMed ID: 22449193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of antigen Ag43 in uropathogenic Escherichia coli Dr+ strains and defining its role in the pathogenesis of urinary tract infections.
    Zalewska-Pia Tek B; Pia Tek R; Olszewski M; Kur J
    Microbiology (Reading); 2015 May; 161(Pt 5):1034-1049. PubMed ID: 25743156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J; de Boer AR; Wuhrer M; Bouckaert J
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
    Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
    FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasion of Host Cells and Tissues by Uropathogenic Bacteria.
    Lewis AJ; Richards AC; Mulvey MA
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28087946
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Stærk K; Grønnemose RB; Nielsen TK; Petersen NA; Palarasah Y; Torres-Puig S; Møller-Jensen J; Kolmos HJ; Lund L; Andersen TE
    Microbiology (Reading); 2021 Oct; 167(10):. PubMed ID: 34623231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics.
    Kostakioti M; Hultgren SJ; Hadjifrangiskou M
    Virulence; 2012 Nov; 3(7):592-4. PubMed ID: 23154288
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual ligand/receptor interactions activate urothelial defenses against uropathogenic E. coli.
    Liu Y; Mémet S; Saban R; Kong X; Aprikian P; Sokurenko E; Sun TT; Wu XR
    Sci Rep; 2015 Nov; 5():16234. PubMed ID: 26549759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.